Efficacy of Cantharidin in Molluscum Contagiosum

Completed · Not applicable

Conditions studied: Molluscum Contagiosum, Skin Disease

In brief

The University of North Carolina Department of Dermatology is conducting a clinical trial to evaluate a drug called cantharidin in the treatment of molluscum contagiosum. Molluscum is a common dermatologic disorder caused by a poxvirus. Molluscum typically presents with many flesh-colored bumps on the skin. It goes away on its own, though can last several months to several years. Cantharidin is a topical medicine which is applied at the clinic visit. It is well tolerated by the majority of children.

Key facts

Study ID

NCT00667225

Run by

University of North Carolina, Chapel Hill

People needed

29

Starts

2008-01-01

Expected to finish

2009-06-01

Last updated by the study team

2011-06-21

Who can join

Age: 5 and older, up to 10. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Anyone aged 5-10 years with the clinical diagnosis of molluscum contagiosum.

You may not qualify if…

• Anyone with immunosuppression including HIV or previous organ transplantation.
• Anyone taking immunosuppressive medications.
• Anyone who has previously received treatment with cantharidin.
• Any female who has had her first menstrual period.

Where it is running

• University of North Carolina — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.